Baidu
map

Neurology:超20万人群研究证实,多吃素可将卒中风险降低10%

2021-03-11 MedSci原创 MedSci原创

俗话说的好,民以食为天。“吃”一件重要的事,也是是一件快乐的事,健康合理均衡的饮食不仅能保持机体的健康,也能带来很多快乐。

俗话说的好,民以食为天。一件重要的事,也是是一件快乐的事,健康合理均衡的饮食不仅能保持机体的健康,也能带来很多快乐。诸多研究显示,多吃蔬菜水果对健康有益,有助于降低众多慢性疾病的发生风险,而这些慢病是导致死亡的主要原因,包括血管疾病和癌症等。

近日,发表在Neurology杂志的一项研究显示,增加植物性饮食的摄入量,包括蔬菜,全谷物和豆类食物,减少摄取较不健康的食物(如精制谷物或添加的糖)的摄入量,可使中风的风险降低10%。

在这项研究中,研究人员收纳了护士健康研究(NHS1984年至2016年)中的73,890名女性,NHSII1991年至2017年)中的92,352名女性,以及健康专业人员随访研究(1986年至2012年)中的43,266名男性,共涉及209508名参与者,这些参与者基线时无心血管疾病和癌症。参与者每24年完成一次问卷调查,询问上一年不同食物的饮食频率。

研究人员根据饮食质量将参与者分为五类,特别是较高量的植物性食品,但不排除所有动物性食品。例如,与饮食质量最低的人相比,饮食质量最高的参与者平均每天食用12份健康的植物性食品,例如绿叶蔬菜,水果,全谷类,豆类和植物油。对于不健康的植物性食品,例如谷物和谷物等具有高糖指数的蔬菜,例如玉米和土豆,饮食最健康的参与者平均每天3份,而饮食最低质量的参与者平均每天6份。至于肉类和奶制品,饮食最健康的人平均每天3.5份,而饮食质量最低的人每天6份。

参与人员报告其肉类和/或鱼类摄入量为零或每月少于一份的参与者被归类为素食者,其他参与者被归类为非素食者。最后,通过总体植物性饮食指数(PDI)、健康的PDIhPDI)和不健康的PDIuPDI)对植物性饮食质量进行评估。

结果显示,随访25年,共有6241名参与者发生卒中,包括3015名缺血性卒中和853例出血性卒中)。与PDI最低的参与者相比,PDI最高的参与者的总卒中的风险比(HRs)为0.9495%置信区间0.861.03),hPDI 0.900.830.98),uPDI1.050.961.15)。最高hPDI的参与者,缺血性卒中的HR略低(0.92[0.821.04]),且与出血性卒中没有一致的关联。另外,素食与总卒中(1.00[0.761.32])之间没有关联,尽管病例数很少。

总之,坚持健康的以植物为基础的饮食的人发现总中风的风险较低。虽然在三分之一的卒中患者尚不知道卒中的类型,但以植物性饮食为基础的饮食中发现缺血性卒中的风险较低,总卒中的风险较低。然而,该研究也存在一定的局限性,所有参与者均为卫生专业人员,并且主要是白人,这意味着结果可能不适用于一般人群。

原始出处

Megu Baden, Zhilei Shan, Fenglei Wang, Yanping Li, JoAnn E. Manson, Eric B. Rimm, Walter C. Willett, Frank B. Hu, Kathryn M. Rexrode, Quality of Plant-based Diet and Risk of Total, Ischemic, and Hemorrhagic Stroke," Neurology, online March 10, 2021, dx.doi.org/10.1212/WNL.0000000000011713

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2022-02-19 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-04-27 Lvis

    厉害了!!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-04-06 小漂漂

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-13 ms5000001705232564

    感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-11 澄潭映月

    所说的份是多少

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-11 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-11 guging

    中风是俗称,应该称为缺血性卒中吧

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1820715, encodeId=33001820e15ca, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Fri Jan 07 07:06:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001252, encodeId=4790200125274, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Feb 19 23:06:00 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961075, encodeId=dccf9610e526, content=厉害了!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200603/2a637bcd7f5d495c8010807afb152098/bcec19e3426f4848acd5947f8a2d0c0c.jpg, createdBy=8f8e2056735, createdName=Lvis, createdTime=Tue Apr 27 23:27:27 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954194, encodeId=6f86954194da, content=啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erWJico0ibp27oibJPCS8SmZM7y1TKiagNtgdXogiaY5VZCXhOND0ED8oPW5wwd8AHEEIhCsAF0ybILaVQ/132, createdBy=84885319965, createdName=小漂漂, createdTime=Tue Apr 06 13:38:36 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947794, encodeId=76ec94e794e9, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b4d5468550, createdName=ms5000001705232564, createdTime=Sat Mar 13 07:29:10 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281364, encodeId=9b0d128136425, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Sat Mar 13 02:06:00 CST 2021, time=2021-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947397, encodeId=87e394e397f6, content=所说的份是多少, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51784848823, createdName=澄潭映月, createdTime=Thu Mar 11 14:41:05 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026791, encodeId=ee141026e9155, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046031, encodeId=4f351046031d3, content=中风是俗称,应该称为缺血性卒中吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=guging, createdTime=Thu Mar 11 14:06:00 CST 2021, time=2021-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947377, encodeId=34f894e3772b, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22555467880, createdName=ms2000000848663178, createdTime=Thu Mar 11 12:16:53 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-11 ms2000000848663178

    挺好的

    0

相关资讯

Stroke:卒中后长期服用普拉格雷或氯吡格雷治疗的血压和变异性水平

较高的平均SBP水平和随访变异性与普拉格雷或氯吡格雷长期治疗期间卒中复发的风险显着相关。无论使用哪种抗血小板药物,控制高血压都尤为重要。

Lancet:牛津大学研究发现“非典型小卒中”的危害大到你想不到

与典型TIA发作相比,非典型TIA发作患者具有较高的早期和长期中风风险。将症状不典型的患者考虑入内后,TIA诊断将增加约50%。

Lancet Neurology:无症状颈动脉狭窄程度与卒中风险的关系:一项基于人群的队列研究、系统回顾和荟萃分析

两项大型的随机对照试验证明,颈动脉内膜切除术对于近期有症状的颈动脉狭窄患者预防卒中的益处,其所观察到的益处在很大程度上取决于狭窄程度。

Gut:卒中引起的肠道菌群紊乱加重脑梗死

卒中与肠道菌群紊乱之间的相互关系。缺血性卒中会迅速引发肠道菌群紊乱,肠杆菌过度生长,进而加剧脑梗塞。

Stroke:采用非维生素K拮抗剂口服抗凝药预防卒中的房颤患者脑出血危险因素分析

一些危险因素与服用NOAC预防卒中的患者ICH发生相关,但HAS-BLED和CHA2DS2-VASc得分与其无关。

JACC:1.4万人双盲随机试验| 不同剂量的依度沙班预防房颤患者卒中的净临床结局

在ENGAGE AF-TIMI 48试验中,低剂量依度沙班(edoxaban)方案(LDER)和高剂量依度沙班方案(HDER)在预防心房颤动卒中的效果不逊于管理良好的华法林。

Baidu
map
Baidu
map
Baidu
map